ASLAN Pharmaceuticals Ltd Quarterly Liabilities in USD from Q4 2017 to Q4 2023

Taxonomy & unit
ifrs-full: USD
Summary
ASLAN Pharmaceuticals Ltd quarterly Liabilities history and growth rate from Q4 2017 to Q4 2023.
  • ASLAN Pharmaceuticals Ltd Liabilities for the quarter ending December 31, 2023 was $37.9M, a 28.2% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $37.9M -$14.9M -28.2% Dec 31, 2023 20-F 2024-04-12
Q2 2023 $48.8M +$890K +1.86% Jun 30, 2023 6-K 2023-08-11
Q4 2022 $52.8M +$15.6M +41.9% Dec 31, 2022 20-F 2024-04-12
Q2 2022 $47.9M +$27.3M +132% Jun 30, 2022 6-K 2022-08-12
Q4 2021 $37.2M +$11M +41.9% Dec 31, 2021 20-F 2023-03-24
Q2 2021 $20.7M -$2.29M -9.99% Jun 30, 2021 6-K 2021-08-06
Q4 2020 $26.2M +$2.28M +9.52% Dec 31, 2020 20-F 2022-03-25
Q3 2020 $24.8M +$5.62M +29.3% Sep 30, 2020 6-K 2021-01-29
Q2 2020 $23M Jun 30, 2020 6-K 2020-10-09
Q4 2019 $24M +$1.69M +7.59% Dec 31, 2019 20-F 2021-04-23
Q3 2019 $19.2M Sep 30, 2019 6-K 2019-10-31
Q4 2018 $22.3M +$6.44M +40.7% Dec 31, 2018 20-F 2020-04-16
Q4 2017 $15.8M Dec 31, 2017 20-F 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.